No Data
Trending Industry Today: WUXI APPTEC Leads Losses In Biotechnology Stocks
Trending Industry Today: PHARMARON Leads Losses In CRO Stocks
Hong Kong stocks fluctuate | CRO concept continues to decline, domestic biomedical investment and financing still at the bottom, overseas business development uncertainty increases.
CRO concept stocks continue to decline. As of the time of writing, wuxi apptec (02359) is down 6.13%, trading at 45.9 Hong Kong dollars; tigermed (03347) is down 5.88%, trading at 32 Hong Kong dollars; pharmaron (03759) is down 5.71%, trading at 13.2 Hong Kong dollars.
Genscript bio (01548) issued 4.18 million shares due to options exercised.
Genscript bio (01548) announced that the company will... on November 18, 2024, according to the 2015...
Genscript Biotech Enters Sub-License Contract for Anti-PD-1 Single Domain Antibodies
Genscript bio (01548.HK): Nanjing Pengbo has reached a licensing agreement with Lixin Medical Technology Co., Ltd.
Gelonghui November 15th | Genscript Bio (01548.HK) announced that on November 12, 2024, its non-wholly owned subsidiary Nanjing Pongbo Technology Co., Ltd. ("Nanjing Pongbo") entered into a restated and amended license agreement with Lixin Pharmaceutical Technology Co., Ltd. ("Lixin"). Pursuant to the agreement, Nanjing Pongbo agrees to grant Lixin an exclusive global transferable license, with the right to further sublicense, allowing it to develop, produce, commercialize, and
Genscript Biotech Corporation's (HKG:1548) P/S Is Still On The Mark Following 29% Share Price BounceNo Data
No Data
